At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 290 enrolled
Drug / intervention
Terbinafine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study of the Efficacy and Safety of Terbinafine Film Forming Solution, 1% (as Hydrochloride), in Patients With Tinea Pedis
In Brief
A Phase 3 clinical trial evaluating Terbinafine and Terbinafine Placebo for Tinea Pedis. Completed, enrolled 290 participants across 6 sites.
Detailed Summary
This study will compare the efficacy and safety of a single dose of terbinafine film forming solution 1% with a single dose of placebo film forming solution in the treatment of tinea pedis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTinea Pedis
CountriesChina
Collaborators--
Timeline
Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2011
First PostedSep 2011
Primary CompletionFeb 2012
TodayJul 2026
First PostedSep 13, 2011
Enrollment StartAug 1, 2011
Primary CompletionFeb 1, 2012
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 14.8 years ago
Interventions
Terbinafinedrug
1% single application
Terbinafine Placebodrug
single application